Health Affairs · 2007 · 131 citations · 21 references
PharmacyCardiologyPharmacoeconomicsClinical EpidemiologyCost-effectiveness AnalysisPharmacoeconomic ModelingBlood Pressure ControlBlood Pressure ManagementCardiovascular DiseaseHypertension ControlHypertension ManagementPharmacoepidemiologyAntihypertensive Drug TherapyAntihypertensive Medication ManagementAntihypertensive TreatmentBenefit-risk RatioBlood Pressure Reduction Policy ImpactCardiovascular Disease IncidenceCardiovascular Disease ManagementCardiovascular Disease Mortality
Using national survey data and risk equations from the Framingham Heart Study, we quantify the impact of antihypertensive therapy changes on blood pressures and the number and cost of heart attacks, strokes, and deaths. Antihypertensive therapy has had a major impact on health. Without it, 1999-2000 average blood pressures (at age 40+) would have been 10-13 percent higher, and 86,000 excess premature deaths from cardiovascular disease would have occurred in 2001. Treatment has generated a benefit-to-cost ratio of at least 6:1, but much more can be achieved. More effective use of antihypertensive medication would have an impact on mortality akin to eliminating all deaths from medical errors or accidents.
21
Prediction of Coronary Heart Disease Using Risk Factor Categories
Peter W.F. Wilson, Ralph B. D’Agostino, Daniel Levy et al. · Circulation · 1998 · 9.6K citations
Andrew Wall · British Journal of Healthcare Management · 2000 · 5.9K citations
Health Professions, Health Policy, Health Services Administration +8
Cardiovascular disease risk profiles
Keaven M. Anderson, Patricia M. Odell, Peter W.F. Wilson et al. · American Heart Journal · 1991 · 2.2K citations · Full text